Audit commitee

Audit commitee

BioGaia’s board has appointed an Audit Committee.

The key task of the Audit Committee is to support the Board with quality assurance of the financial reporting. The Audit Committee also prepares matters relating to regulatory compliance.

The committee holds regular meetings with the company’s auditors and evaluates audit work. The committee discusses significant accounting issues that affect the Group and assists the Nominating Committee in the preparation of proposals for auditors and their remuneration. The chairman of the Audit Committee is responsible for ensuring that the entire Board is kept informed about the work of the committee as well as, when necessary, presenting the Board with matters for decision.

The Audit Committee’s members consists of

BioGaia Anthon Jahreskog

Anthon Jahreskog

BOARD MEMBER

Born in 1980. Elected to the Board in 2015. Holds a bachelor’s degree in Management and Systems from City, University of London and a master’s degree in Financial Management from the University of Cape Town. Former Chief Operating Officer Fund Linked Products at Credit Suisse Investment Bank, London. Other board assignments: Infant Bacterial Therapeutics AB (IBT). Holds 2,890 class B shares.

Read more Close
BioGaia David Dangoor

David Dangoor

BOARD VICE CHAIRMAN

Born in 1949. Board Vice Chairman. Elected to the Board in 2003. BioGaia Board Chairman 2007–2018. MBA from the Stockholm School of Economics. Marketing and PR consultant. President of Innoventive Partners LLC. Former Executive Vice President and Marketing Director at Philip Morris USA and Philip Morris International. Other board assignments: New York City Ballet Inc., School of Creative Leadership, Berlin University and Swedish-American Chamber of Commerce (chairman 1997–2001). Holds 1,750,000 class B shares.

Read more Close

Related content